Clinical trials
Hyperandrogenism trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2006 | 3 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Unknown status | 6 |
| Recruiting | 3 |
| Terminated | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Virginia | 3 |
| AGUNCO Obstetrics and Gynecology Centre | 1 |
| Aarhus University Hospital Skejby | 1 |
| Behnood Abbasi | 1 |
| Catholic University of the Sacred Heart | 1 |
| Charite University, Berlin, Germany | 1 |
| Dhivyaprasath Palaniappan | 1 |
| Diana Speelman, Ph.D. | 1 |
| Federal University of São Paulo | 1 |
| Fundacion Dexeus | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperandrogenism | 26 |
| Polycystic Ovary Syndrome | 19 |
| Insulin Resistance | 8 |
| Metabolic Syndrome | 4 |
| Obesity | 4 |
| Hirsutism | 3 |
| Menstruation Disturbances | 2 |
| Anovulation | 1 |
| Dyslipidemias | 1 |
| Endocrine System Diseases | 1 |
Trials
Showing 76 to 26 of 26. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.